a2m
  • a2m
  • Services
    • Strategy
    • Market Access and Reimbursement
    • Health Economic Modelling
    • Pricing and Valuation
    • Biotechnology
    • Nutrition
  • Capabilities
  • Latest News
  • About
  • Contact
  • Publications
  • Home
  • Latest News

Latest News

Increasing interest in our Pricing Model and Algorithm for "expensive" drugs

Mark Nuijten

Lees meer

The true prices of drugs

Mark Nuijten

Lees meer

De echte prijs van geneesmiddelen

Mark Nuijten

Lees meer

A2M - Minerva in Vienna at ISPOR

Mark Nuijten

Lees meer

ISPOR Vienna

Mark Nuijten

Lees meer

Evaluation and valuation of ultra-innovative drugs: a new concept

Mark Nuijten

Lees meer

Presentation of NICE model at European Hematology Association

Mark Nuijten

Lees meer

Valuation tool for biotechnology

Mark Nuijten

Lees meer

Valuation of innovation

Mark Nuijten

Lees meer

Economics of obesity

Mark Nuijten

Lees meer

  • «
  • 1
  • 2
  • »
Latest News Blog
  • Increasing interest in our Pricing Model and Algorithm for "expensive" drugs
  • The true prices of drugs
  • De echte prijs van geneesmiddelen
Copyright by a2m, Mark Nuijten, 2018. All rights reserved.